Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer.

Zhao SG, Jackson WC, Kothari V, Schipper MJ, Erho N, Evans JR, Speers C, Hamstra DA, Niknafs YS, Nguyen PL, Schaeffer EM, Ross AE, Den RB, Klein EA, Jenkins RB, Davicioni E, Feng FY.

Prostate Cancer Prostatic Dis. 2015 May 19. doi: 10.1038/pcan.2015.22. [Epub ahead of print]

PMID:
25986914
2.

Quercetin regulates β-catenin signaling and reduces the migration of triple negative breast cancer.

Srinivasan A, Thangavel C, Liu Y, Shoyele S, Den RB, Selvakumar P, Lakshmikuttyamma A.

Mol Carcinog. 2015 May 12. doi: 10.1002/mc.22318. [Epub ahead of print]

PMID:
25968914
3.

Characterization of 1577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathologic Insights into Molecular Subtypes.

Tomlins SA, Alshalalfa M, Davicioni E, Erho N, Yousefi K, Zhao S, Haddad Z, Den RB, Dicker AP, Trock BJ, DeMarzo AM, Ross AE, Schaeffer EM, Klein EA, Magi-Galluzzi C, Karnes RJ, Jenkins RB, Feng FY.

Eur Urol. 2015 May 8. pii: S0302-2838(15)00375-9. doi: 10.1016/j.eururo.2015.04.033. [Epub ahead of print]

PMID:
25964175
4.

Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysis.

Lobo JM, Dicker AP, Buerki C, Daviconi E, Karnes RJ, Jenkins RB, Patel N, Den RB, Showalter TN.

PLoS One. 2015 Apr 2;10(3):e0116866. doi: 10.1371/journal.pone.0116866. eCollection 2015.

5.

Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies.

Dan TD, Eldredge-Hindy HB, Hoffman-Censits J, Lin J, Kelly WK, Gomella LG, Lallas CD, Trabulsi EJ, Hurwitz MD, Dicker AP, Den RB.

Am J Clin Oncol. 2015 Feb 25. [Epub ahead of print]

PMID:
25723740
6.

Novel actions of next-generation taxanes benefit advanced stages of prostate cancer.

de Leeuw R, Berman-Booty LD, Schiewer MJ, Ciment SJ, Den RB, Dicker AP, Kelly WK, Trabulsi EJ, Lallas CD, Gomella LG, Knudsen KE.

Clin Cancer Res. 2015 Feb 15;21(4):795-807. doi: 10.1158/1078-0432.CCR-14-1358.

PMID:
25691773
7.

Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.

Den RB, Yousefi K, Trabulsi EJ, Abdollah F, Choeurng V, Feng FY, Dicker AP, Lallas CD, Gomella LG, Davicioni E, Karnes RJ.

J Clin Oncol. 2015 Mar 10;33(8):944-51. doi: 10.1200/JCO.2014.59.0026. Epub 2015 Feb 9.

PMID:
25667284
8.

Is robotic arm stereotactic body radiation therapy 'virtual high-dose rate brachytherapy' effective for prostate cancer? An analysis of comparative effectiveness using published data.

Zaorsky NG, Hurwitz MD, Dicker AP, Showalter TN, Den RB.

Expert Rev Med Devices. 2015 May;12(3):317-27. doi: 10.1586/17434440.2015.994606. Epub 2014 Dec 25.

PMID:
25540018
9.

RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.

Prensner JR, Zhao S, Erho N, Schipper M, Iyer MK, Dhanasekaran SM, Magi-Galluzzi C, Mehra R, Sahu A, Siddiqui J, Davicioni E, Den RB, Dicker AP, Karnes RJ, Wei JT, Klein EA, Jenkins RB, Chinnaiyan AM, Feng FY.

Lancet Oncol. 2014 Dec;15(13):1469-80. doi: 10.1016/S1470-2045(14)71113-1. Epub 2014 Nov 17.

PMID:
25456366
10.

Effect of docetaxel on safety and efficacy of radium-223.

Den RB, Kelly WK.

Lancet Oncol. 2014 Nov;15(12):1292-3. doi: 10.1016/S1470-2045(14)71026-5. Epub 2014 Oct 17. No abstract available.

PMID:
25439686
11.

Predictors of positive surgical margins after radical prostatectomy at a single institution: preoperative and pathologic factors, and the impact of surgeon variability and technique on incidence and location.

Lallas CD, Fashola Y, Den RB, Gelpi-Hammerschmidt F, Calvaresi AE, McCue P, Birbe R, Gomella LG, Trabulsi EJ.

Can J Urol. 2014 Oct;21(5):7479-86.

PMID:
25347375
12.

Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer.

Eldredge-Hindy HB, Eastwick G, Anne PR, Rosenblum NG, Schilder RJ, Chalian R, Zibelli AM, Kim CH, Den R.

J Contemp Brachytherapy. 2014 Oct;6(3):262-70. doi: 10.5114/jcb.2014.45031. Epub 2014 Sep 5.

13.

Uncertainties encountered in implementation of adaptive planning with in vivo dosimeters.

Studenski MT, Gardner SJ, Den RB.

Radiol Phys Technol. 2015 Jan;8(1):81-7. doi: 10.1007/s12194-014-0291-0. Epub 2014 Sep 19.

PMID:
25236778
14.

Timing of adjunctive therapy in the treatment of depression: a chart review.

Tarumi R, Suzuki T, Tani H, Den R, Sawada N, Sakurai H, Tsutsumi-Ozawa C, Ohtani A, Mimura M, Uchida H.

Pharmacopsychiatry. 2014 Nov;47(7):259-62. doi: 10.1055/s-0034-1387784. Epub 2014 Sep 2.

PMID:
25181576
15.

The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness.

Thangavel C, Boopathi E, Ciment S, Liu Y, O' Neill R, Sharma A, McMahon SB, Mellert H, Addya S, Ertel A, Birbe R, Fortina P, Dicker AP, Knudsen KE, Den RB.

Clin Cancer Res. 2014 Nov 1;20(21):5468-82. doi: 10.1158/1078-0432.CCR-14-0326. Epub 2014 Aug 27.

PMID:
25165096
16.

The lag time in initiating clinical testing of new drugs in combination with radiation therapy, a significant barrier to progress?

Blumenfeld P, Pfeffer RM, Symon Z, Den RB, Dicker AP, Raben D, Lawrence YR.

Br J Cancer. 2014 Sep 23;111(7):1305-9. doi: 10.1038/bjc.2014.448. Epub 2014 Aug 12.

PMID:
25117813
17.

Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy.

Den RB, Feng FY, Showalter TN, Mishra MV, Trabulsi EJ, Lallas CD, Gomella LG, Kelly WK, Birbe RC, McCue PA, Ghadessi M, Yousefi K, Davicioni E, Knudsen KE, Dicker AP.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1038-46. doi: 10.1016/j.ijrobp.2014.04.052. Epub 2014 Jul 8.

18.

Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma.

Yamoah K, Eldredge-Hindy HB, Zaorsky NG, Palmer JD, Doyle LA, Sendecki JA, Hesney AA, Harper L, Repka M, Showalter TN, Hurwitz MD, Dicker AP, Den RB.

Brachytherapy. 2014 Sep-Oct;13(5):456-64. doi: 10.1016/j.brachy.2014.04.003. Epub 2014 Jun 18.

PMID:
24953945
19.

Practical guide to the use of radium 223 dichloride.

Den RB, Doyle LA, Knudsen KE.

Can J Urol. 2014 Apr;21(2 Supp 1):70-6. Review.

20.

A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer.

Zaorsky NG, Yamoah K, Thakur ML, Trabulsi EJ, Showalter TN, Hurwitz MD, Dicker AP, Den RB.

Future Oncol. 2014 Feb;10(3):457-74. doi: 10.2217/fon.13.196. Review.

PMID:
24559451
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk